Brief: Baudax Bio Reports First Quarter 2022 Results
04/05/2022 22:40
May 4 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
BUSINESS HIGHLIGHTS
* BAUDAX BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
BUSINESS HIGHLIGHTS
* BAUDAX BIO INC - AS OF MARCH 31, 2022, BAUDAX BIO HAD CASH
AND
CASH EQUIVALENTS OF $11.5 MILLION
* BAUDAX BIO INC - REPORTED NET LOSS OF $3.17 PER SHARE, FOR
THREE
MONTHS ENDED MARCH 31, 2022
Source text for Eikon: ID:nGNX1Rdx3S
Further company coverage: BXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer